British pharma giant AstraZeneca to invest $2.5 billion in new China hub
CNBCยท2025-03-21 11:10Group 1 - AstraZeneca will invest $2.5 billion in a research and development center in Beijing, China [1] - The new hub is expected to increase AstraZeneca's workforce in Beijing to approximately 1,700 employees [1] - The announcement coincides with an upcoming interview of AstraZeneca's CEO Pascal Soriot on CNBC International [1]